ストックスクリーナーアプリを入手
37.89
0.58%
-0.22
Kiniksa Pharmaceuticals International Plc (KNSA) 最新ニュース
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Robeco Institutional Asset Management B.V. Buys New Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Rating Lowered to "Hold" at Zacks Research - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Stock Position Reduced by Knights of Columbus Asset Advisors LLC - MarketBeat
Wealth Enhancement Advisory Services LLC Has $430,000 Stake in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Here's What Could Help Kiniksa Pharmaceuticals International, plc (KNSA) Maintain Its Recent Price Strength - Yahoo Finance
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Rating Lowered to Buy at Wall Street Zen - MarketBeat
Kiniksa Pharmaceuticals Hits New 52-Week High of USD 39.12 - Markets Mojo
AMI Asset Management Corp Sells 34,547 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 42,000 Shares of Stock - MarketBeat
Kiniksa Pharmaceuticals Hits New 52-Week High of $38.97 - Markets Mojo
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Now Covered by TD Cowen - Defense World
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week HighWhat's Next? - MarketBeat
KNSA: TD Cowen Initiates Coverage with 'Buy' Rating and $60 PT | - GuruFocus
TD Cowen Initiates Kiniksa Pharmaceuticals International at Buy With $60 Price Target - MarketScreener
Risk vs reward if holding onto Kiniksa Pharmaceuticals Ltd.Quarterly Investment Review & Long-Term Safe Return Strategies - newser.com
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Given New $45.00 Price Target at Wells Fargo & Company - Defense World
Voya Investment Management LLC Buys 10,878 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
CDTX Stock Soars 218% YTD on Positive Updates From Influenza Program - The Globe and Mail
Wells Fargo Raises KNSA Price Target to $45, Maintains Overweigh - GuruFocus
Wells Fargo & Company Forecasts Strong Price Appreciation for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience - sharewise.com
Strs Ohio Acquires Shares of 26,800 Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Goldman Sachs Group Inc. Has $3.47 Million Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Pallas Capital Advisors LLC Buys New Shares in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
10,700 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Acquired by Toth Financial Advisory Corp - MarketBeat
Strs Ohio Purchases Shares of 26,800 Kiniksa Pharmaceuticals International, plc $KNSA - Defense World
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Short Interest Update - MarketBeat
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells $597,944.00 in Stock - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Holdings Raised by Rhumbline Advisers - Defense World
Kiniksa Pharmaceuticals International, plc (KNSA) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives $41.17 Average PT from Analysts - MarketBeat
What high frequency data says about Kiniksa Pharmaceuticals Ltd.Market Weekly Review & Safe Capital Growth Tips - newser.com
Fred Alger Management LLC Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Holdings Raised by AQR Capital Management LLC - MarketBeat
Kiniksa Pharmaceuticals International, plc $KNSA Shares Purchased by Acadian Asset Management LLC - MarketBeat
Using fundamentals and technicals on Kiniksa Pharmaceuticals Ltd.July 2025 Decliners & Long-Term Growth Plans - newser.com
Kiniksa Pharmaceuticals COO Tessari Eben sells $273,980 in shares - MSN
Backtesting results for Kiniksa Pharmaceuticals Ltd. trading strategiesRisk Management & Free High Accuracy Swing Entry Alerts - newser.com
Exploring High Growth Tech Stocks in the US Market September 2025 - simplywall.st
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighStill a Buy? - MarketBeat
Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Insider Sells 3,523 Shares of Stock - MarketBeat
Eben Tessari Sells 13,389 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat
Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 85,271 Shares of Stock - MarketBeat
RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal - The Globe and Mail
American Century Companies Inc. Trims Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
1.54%
1.20%
大文字化:
|
ボリューム (24 時間):